Quick Take
InMode (INMD) went public in August, 2019, selling five million shares at $14.00 to collect $70 million in gross proceeds.
The firm has been commercializing its adipose fat tissue remodeling technologies.
INMD has managed its business through the Covid-19 pandemic for long-term success and is positioned to meet or slightly exceed 2019’s revenue results, so I’m Bullish on the stock over the medium term.
Company
Yokneam, Israel-based InMode was founded in 2008 to provide minimally-invasive face and body contouring, medical aesthetics and women’s health products and solutions.
Management is headed by